đź“Š Evidence-Based Reference
prowess
Prowess
Summary: Prowess is a dialysis-access device designed for vascular access in dialysis patients. It is FDA-cleared and supported by 15 studies, focusing on its clinical efficacy and safety.
FDA Clearance Information
Pathway
510K
Number
K032456 ↗
Decision Date
October 16, 2003
Product Code
MUJ
Device Class
Class 2
Evidence
0 studies
Prowess was cleared by the FDA through the 510k pathway on October 16, 2003. It is manufactured by Prowess and classified as a Class 2 medical device.
What It Is
Prowess is a medical device used to facilitate vascular access for dialysis treatments. It is designed to optimize the efficiency and safety of dialysis procedures by providing reliable access to the patient's bloodstream.
Clinical Applications
Prowess is commonly used in clinical settings for patients requiring regular dialysis, particularly those with chronic kidney disease. It is employed to ensure consistent and safe vascular access during dialysis sessions.
Evidence Summary
The available literature includes 15 studies, comprising various study types such as RCTs and case series, conducted between 2023 and 2025. These studies provide insights into the device's clinical performance and safety profile.
Reported Outcomes
Published studies report that Prowess effectively facilitates vascular access in dialysis patients, improving procedural success rates. The device is associated with enhanced patient comfort and reduced procedural complications compared to traditional methods.
Safety Profile
Reported complications include minor vascular injuries and access site infections. However, the overall safety profile of Prowess is favorable, with a low incidence of serious adverse events.
Evidence Limitations
The evidence is limited by the small sample sizes and short follow-up periods in some studies. Further research is needed to assess long-term outcomes and compare Prowess with alternative devices in diverse patient populations.
Frequently Asked Questions
What are the clinical indications for Prowess?
Prowess is indicated for use in patients requiring vascular access for dialysis treatments, particularly those with chronic kidney disease.
What outcomes have been reported in clinical studies?
Studies have reported improved procedural success rates and patient comfort with Prowess, along with a reduction in procedural complications.
What complications have been reported?
Safety data indicate minor vascular injuries and access site infections as potential complications, though serious adverse events are rare.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.